
11 - 50 employees
Founded 2024
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
💰 $300M Venture Round - GondolaBio on 2024-08
Healthcare • Consulting • Manufacturing
GondolaBio is a clinical-stage biopharmaceutical company launched in 2024 and affiliated with BridgeBio Pharma, focused on developing breakthrough therapeutics for patients with genetic diseases. The company uses a lean, decentralized approach to accelerate early-stage research and development across multiple modalities (including small molecules and oligonucleotide therapies) and is building a diverse pipeline targeting rare and underserved genetic conditions such as EPP/XLP with its lead program PORT-77. GondolaBio centers patient needs and aims to bring disease-modifying treatments more quickly to populations lacking approved therapies.
Selected: 🆕 Date Added.
🕒 3 days ago
Senior Director leading clinical and regulatory medical writing for GondolaBio, a genetic-disease therapeutics biopharmaceutical company. Owning submissions, document quality, timelines, and vendor oversight.
🇺🇸 United States – Remote
💵 $270k - $280k / year
💰 $300M Venture Round - GondolaBio on 2024-08
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 3%
🕒 October 9
Tier 2–3 IT Support Engineer resolving endpoint, identity, application, and security issues for GondolaBio, a clinical-stage biopharmaceutical company developing genetic-disease therapeutics.
🇺🇸 United States – Remote
💵 $55 / hour
💰 $300M Venture Round - GondolaBio on 2024-08
⏳ Contract/Temporary
🟡 Mid-level
🟠 Senior
📞 Support Engineer
👻 Ghost score 3%
🕒 October 2
Principal Scientist advancing GondolaBio’s genetic-disease therapeutics through in vivo neurology pharmacology. Designing rodent and primate studies toward IND submission and dose-selection decisions.
🏄 California – Remote
💵 $173k - $205k / year
💰 $300M Venture Round - GondolaBio on 2024-08
⏰ Full Time
🔴 Lead
🧬 Research Scientist
👻 Ghost score 3%
🕒 September 15
Senior Director leading global Phase 1-4 clinical trials for GondolaBio, a biopharmaceutical company developing genetic-disease therapeutics. Driving operational strategy, vendors, sites, enrollment, and inspection readiness.
🏄 California – Remote
💵 $244k - $295k / year
💰 $300M Venture Round - GondolaBio on 2024-08
⏰ Full Time
🟠 Senior
🏥 Clinical Operations
👻 Ghost score 3%
🕒 September 4
Director leading field medical affairs for GondolaBio’s genetic-disease therapeutics. Guiding HCP engagement and MSL execution for Portal’s EPP/XLP program.
🇺🇸 United States – Remote
💵 $249k - $454k / year
💰 $300M Venture Round - GondolaBio on 2024-08
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 3%
🕒 August 21
Oligonucleotide toxicology leader guiding nonclinical safety, regulatory submissions, and clinical development. GondolaBio develops genetic-disease therapeutics.
🇺🇸 United States – Remote
💵 $275k - $350k / year
💰 $300M Venture Round - GondolaBio on 2024-08
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 5%
🕒 August 4
Computational biology scientist integrating multiomics and AI analyses for GondolaBio’s genetic-disease therapeutics. Supporting target identification, biomarker discovery, and translational research.
🇺🇸 United States – Remote
💵 $155k - $205k / year
💰 $300M Venture Round - GondolaBio on 2024-08
⏰ Full Time
🟠 Senior
📊 Data Scientist
👻 Ghost score 9%